Press Releases

Date	Title
05-30-2023	Kura Oncology Announces Late-Breaking Abstract Accepted for Oral Presentation at the 2023 European Hematology Association (EHA) Congress
05-23-2023	Kura Oncology to Participate in Two Upcoming Investor Conferences
05-10-2023	Kura Oncology Reports First Quarter 2023 Financial Results
05-09-2023	Kura Oncology to Participate in JMP Securities Life Sciences Conference
05-03-2023	Kura Oncology to Report First Quarter 2023 Financial Results
04-18-2023	Kura Oncology to Participate in Stifel Targeted Oncology Days
04-17-2023	Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Farnesyl Transferase Inhibitor in Combination with Targeted Therapies
03-14-2023	Kura Oncology Announces Acceptance of Two Abstracts for Presentation at AACR Annual Meeting
03-01-2023	Kura Oncology to Participate in Upcoming Investor Conferences
02-23-2023	Kura Oncology Reports Fourth Quarter and Full Year 2022 Financial Results

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

Keyword Search